Teva Pharmaceutical Industries Limited (LON:0LER)

LON:0LER Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,839	19,974	9,188	8,407	6,525	7,746
Market Cap Growth	69.32%	117.40%	9.29%	28.84%	-15.77%	-4.14%
Enterprise Value	37,884	32,974	23,815	25,127	23,592	26,251
Last Close Price	23.30	17.55	8.19	7.50	5.86	6.94
PE Ratio	50.60	-	-	-	21.19	-
PS Ratio	2.15	1.51	0.74	0.68	0.56	0.64
PB Ratio	4.97	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	62.42	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	33.84	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	3.04	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	10.77	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	14.24	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	88.10	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.36	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.61	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	29.57	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.30	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.52	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.11	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	9.71%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.49%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.95%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	1.98%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	1.60%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.